***This too will get the lock if and when the same old banter hits the scene.
There are far too many physicians using hydroxychloroquine with success to ignore their claims. The study linked below found 91.6% clinical improvement in 2,197 of 2,333 patients. As for new drugs, Gilead's remdesivir is under continuous study as well with recent reported 63% clinical improvement. Not sure on that number as I can't find it back now. Link to the remdesivir report at the bottom of this post.
This was released by the Association of American Physicians and Surgeons on findings of 2,333 patients.
AAPS Letter Asking Gov. Ducey to Rescind Executive Order concerning hydroxychloroquine in COVID-19
Inside that letter are these links:
--- Peer Review: Sequential CQ / HCQ Research Papers and Reports--January to April 20, 2020
---The probabilities of clinical success using hydroxychloroquine with or without azithromycin +/-zinc against the novel betacoronavirus, SARS-CoV-2
--------------------------------------------------
In other news:
Critical study of Gilead’s Covid-19 drug shows patients are responding to treatment, NIH says
There are far too many physicians using hydroxychloroquine with success to ignore their claims. The study linked below found 91.6% clinical improvement in 2,197 of 2,333 patients. As for new drugs, Gilead's remdesivir is under continuous study as well with recent reported 63% clinical improvement. Not sure on that number as I can't find it back now. Link to the remdesivir report at the bottom of this post.
This was released by the Association of American Physicians and Surgeons on findings of 2,333 patients.
AAPS Letter Asking Gov. Ducey to Rescind Executive Order concerning hydroxychloroquine in COVID-19
Inside that letter are these links:
--- Peer Review: Sequential CQ / HCQ Research Papers and Reports--January to April 20, 2020
---The probabilities of clinical success using hydroxychloroquine with or without azithromycin +/-zinc against the novel betacoronavirus, SARS-CoV-2
--------------------------------------------------
In other news:
Critical study of Gilead’s Covid-19 drug shows patients are responding to treatment, NIH says
Last edited:
